Everolimus 5mg tablets
NHS hospitals in England used £15,645,675 of indicative cost of Everolimus 5mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 9.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Everolimus 5mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Everolimus 5mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| St George's Univ Hosps Foundation Nhst | £2,372,550 |
| Ruh Bath Nhs Foundation Trust | £1,363,500 |
| The Christie Nhs Foundation Trust | £729,675 |
| East And North Hertfordshire Nhs Trust | £525,450 |
| The Clatterbridge Cancer Centre Nhs Ft | £517,575 |
| Sheffield Teaching Hospitals Nhs Trust | £485,850 |
| Western Sussex Hospitals Nhs Found Trust | £482,625 |
| Univ Hpl B/Ham Nhs Foundation Trust | £456,750 |
| Aintree University Hospital Nhs Ft | £447,750 |
| Nottingham University Hospitals Trust | £441,825 |
The primary-care picture
Everolimus is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Everolimus medicine page.